aluates Reports

$ 0.0

Automative

Global Antisense Oligonucleotides (ASOs) Drugs Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-0F17682

BUY CHAPTERS

Global Antisense Oligonucleotides (ASOs) Drugs Market Research Report 2024

Code: QYRE-Auto-0F17682

Report

May 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Lonis Pharmaceuticals

Novartis

Sanofi

GSK

Sarepta

Kastle

Biogen

Antisense Oligonucleotides (ASOs) Drugs Market

Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).

The global Antisense Oligonucleotides (ASOs) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Antisense Oligonucleotides (ASOs) Drugs include Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, Biogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotides (ASOs) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotides (ASOs) Drugs.

The Antisense Oligonucleotides (ASOs) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antisense Oligonucleotides (ASOs) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense Oligonucleotides (ASOs) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antisense Oligonucleotides (ASOs) Drugs Market Report

Report Metric	Details
Report Name	Antisense Oligonucleotides (ASOs) Drugs Market
Segment by Type	Cleave and Degrade Splice
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antisense Oligonucleotides (ASOs) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antisense Oligonucleotides (ASOs) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotides (ASOs) Drugs Market report?

Ans: The main players in the Antisense Oligonucleotides (ASOs) Drugs Market are Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, Kastle, Biogen

What are the Application segmentation covered in the Antisense Oligonucleotides (ASOs) Drugs Market report?

Ans: The Applications covered in the Antisense Oligonucleotides (ASOs) Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Antisense Oligonucleotides (ASOs) Drugs Market report?

Ans: The Types covered in the Antisense Oligonucleotides (ASOs) Drugs Market report are Cleave and Degrade, Splice

1 Antisense Oligonucleotides (ASOs) Drugs Market Overview

1.1 Product Definition

1.2 Antisense Oligonucleotides (ASOs) Drugs by Type

1.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Cleave and Degrade

1.2.3 Splice

1.3 Antisense Oligonucleotides (ASOs) Drugs by Application

1.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Antisense Oligonucleotides (ASOs) Drugs Market Size Estimates and Forecasts

1.4.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue 2019-2030

1.4.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales 2019-2030

1.4.3 Global Antisense Oligonucleotides (ASOs) Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antisense Oligonucleotides (ASOs) Drugs Market Competition by Manufacturers

2.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antisense Oligonucleotides (ASOs) Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Antisense Oligonucleotides (ASOs) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Product Type & Application

2.7 Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Date of Enter into This Industry

2.8 Global Antisense Oligonucleotides (ASOs) Drugs Market Competitive Situation and Trends

2.8.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antisense Oligonucleotides (ASOs) Drugs Players Market Share by Revenue

2.8.3 Global Antisense Oligonucleotides (ASOs) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antisense Oligonucleotides (ASOs) Drugs Market Scenario by Region

3.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Region: 2019-2030

3.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Region: 2019-2024

3.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Region: 2025-2030

3.3 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Region: 2019-2030

3.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Region: 2019-2024

3.3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Region: 2025-2030

3.4 North America Antisense Oligonucleotides (ASOs) Drugs Market Facts & Figures by Country

3.4.1 North America Antisense Oligonucleotides (ASOs) Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2030)

3.4.3 North America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antisense Oligonucleotides (ASOs) Drugs Market Facts & Figures by Country

3.5.1 Europe Antisense Oligonucleotides (ASOs) Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2030)

3.5.3 Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antisense Oligonucleotides (ASOs) Drugs Market Facts & Figures by Country

3.7.1 Latin America Antisense Oligonucleotides (ASOs) Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2030)

3.7.3 Latin America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2019-2030)

4.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2019-2024)

4.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2025-2030)

4.1.3 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2019-2030)

4.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type (2019-2030)

4.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type (2019-2024)

4.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type (2025-2030)

4.2.3 Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Antisense Oligonucleotides (ASOs) Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2019-2030)

5.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2019-2024)

5.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2025-2030)

5.1.3 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2019-2030)

5.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Application (2019-2030)

5.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Application (2019-2024)

5.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Application (2025-2030)

5.2.3 Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Antisense Oligonucleotides (ASOs) Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Lonis Pharmaceuticals

6.1.1 Lonis Pharmaceuticals Company Information

6.1.2 Lonis Pharmaceuticals Description and Business Overview

6.1.3 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.1.5 Lonis Pharmaceuticals Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Novartis Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Company Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 GSK

6.4.1 GSK Company Information

6.4.2 GSK Description and Business Overview

6.4.3 GSK Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GSK Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.4.5 GSK Recent Developments/Updates

6.5 Sarepta

6.5.1 Sarepta Company Information

6.5.2 Sarepta Description and Business Overview

6.5.3 Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sarepta Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.5.5 Sarepta Recent Developments/Updates

6.6 Kastle

6.6.1 Kastle Company Information

6.6.2 Kastle Description and Business Overview

6.6.3 Kastle Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Kastle Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.6.5 Kastle Recent Developments/Updates

6.7 Biogen

6.7.1 Biogen Company Information

6.7.2 Biogen Description and Business Overview

6.7.3 Biogen Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Biogen Antisense Oligonucleotides (ASOs) Drugs Product Portfolio

6.7.5 Biogen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antisense Oligonucleotides (ASOs) Drugs Industry Chain Analysis

7.2 Antisense Oligonucleotides (ASOs) Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antisense Oligonucleotides (ASOs) Drugs Production Mode & Process

7.4 Antisense Oligonucleotides (ASOs) Drugs Sales and Marketing

7.4.1 Antisense Oligonucleotides (ASOs) Drugs Sales Channels

7.4.2 Antisense Oligonucleotides (ASOs) Drugs Distributors

7.5 Antisense Oligonucleotides (ASOs) Drugs Customers

8 Antisense Oligonucleotides (ASOs) Drugs Market Dynamics

8.1 Antisense Oligonucleotides (ASOs) Drugs Industry Trends

8.2 Antisense Oligonucleotides (ASOs) Drugs Market Drivers

8.3 Antisense Oligonucleotides (ASOs) Drugs Market Challenges

8.4 Antisense Oligonucleotides (ASOs) Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lonis Pharmaceuticals

Novartis

Sanofi

GSK

Sarepta

Kastle

Biogen

List of Tables

Table 1. Global Antisense Oligonucleotides (ASOs) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antisense Oligonucleotides (ASOs) Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Antisense Oligonucleotides (ASOs) Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antisense Oligonucleotides (ASOs) Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antisense Oligonucleotides (ASOs) Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antisense Oligonucleotides (ASOs) Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antisense Oligonucleotides (ASOs) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Antisense Oligonucleotides (ASOs) Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antisense Oligonucleotides (ASOs) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides (ASOs) Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antisense Oligonucleotides (ASOs) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antisense Oligonucleotides (ASOs) Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Antisense Oligonucleotides (ASOs) Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Antisense Oligonucleotides (ASOs) Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antisense Oligonucleotides (ASOs) Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Antisense Oligonucleotides (ASOs) Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Antisense Oligonucleotides (ASOs) Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Antisense Oligonucleotides (ASOs) Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antisense Oligonucleotides (ASOs) Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Lonis Pharmaceuticals Company Information

Table 71. Lonis Pharmaceuticals Description and Business Overview

Table 72. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product

Table 74. Lonis Pharmaceuticals Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Novartis Antisense Oligonucleotides (ASOs) Drugs Product

Table 79. Novartis Recent Developments/Updates

Table 80. Sanofi Company Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Antisense Oligonucleotides (ASOs) Drugs Product

Table 84. Sanofi Recent Developments/Updates

Table 85. GSK Company Information

Table 86. GSK Description and Business Overview

Table 87. GSK Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. GSK Antisense Oligonucleotides (ASOs) Drugs Product

Table 89. GSK Recent Developments/Updates

Table 90. Sarepta Company Information

Table 91. Sarepta Description and Business Overview

Table 92. Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sarepta Antisense Oligonucleotides (ASOs) Drugs Product

Table 94. Sarepta Recent Developments/Updates

Table 95. Kastle Company Information

Table 96. Kastle Description and Business Overview

Table 97. Kastle Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Kastle Antisense Oligonucleotides (ASOs) Drugs Product

Table 99. Kastle Recent Developments/Updates

Table 100. Biogen Company Information

Table 101. Biogen Description and Business Overview

Table 102. Biogen Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Biogen Antisense Oligonucleotides (ASOs) Drugs Product

Table 104. Biogen Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Antisense Oligonucleotides (ASOs) Drugs Distributors List

Table 108. Antisense Oligonucleotides (ASOs) Drugs Customers List

Table 109. Antisense Oligonucleotides (ASOs) Drugs Market Trends

Table 110. Antisense Oligonucleotides (ASOs) Drugs Market Drivers

Table 111. Antisense Oligonucleotides (ASOs) Drugs Market Challenges

Table 112. Antisense Oligonucleotides (ASOs) Drugs Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antisense Oligonucleotides (ASOs) Drugs

Figure 2. Global Antisense Oligonucleotides (ASOs) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antisense Oligonucleotides (ASOs) Drugs Market Share by Type: 2023 & 2030

Figure 4. Cleave and Degrade Product Picture

Figure 5. Splice Product Picture

Figure 6. Global Antisense Oligonucleotides (ASOs) Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Antisense Oligonucleotides (ASOs) Drugs Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global Antisense Oligonucleotides (ASOs) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Antisense Oligonucleotides (ASOs) Drugs Market Size (2019-2030) & (US$ Million)

Figure 12. Global Antisense Oligonucleotides (ASOs) Drugs Sales (2019-2030) & (K Units)

Figure 13. Global Antisense Oligonucleotides (ASOs) Drugs Average Price (US$/Unit) & (2019-2030)

Figure 14. Antisense Oligonucleotides (ASOs) Drugs Report Years Considered

Figure 15. Antisense Oligonucleotides (ASOs) Drugs Sales Share by Manufacturers in 2023

Figure 16. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Share by Manufacturers in 2023

Figure 17. Global 5 and 10 Largest Antisense Oligonucleotides (ASOs) Drugs Players: Market Share by Revenue in Antisense Oligonucleotides (ASOs) Drugs in 2023

Figure 18. Antisense Oligonucleotides (ASOs) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 19. Global Antisense Oligonucleotides (ASOs) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2019-2030)

Figure 21. North America Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2019-2030)

Figure 22. United States Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2019-2030)

Figure 25. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2019-2030)

Figure 26. Germany Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Region (2019-2030)

Figure 33. China Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2019-2030)

Figure 41. Mexico Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Brazil Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Argentina Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Colombia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Antisense Oligonucleotides (ASOs) Drugs by Type (2019-2030)

Figure 51. Global Revenue Market Share of Antisense Oligonucleotides (ASOs) Drugs by Type (2019-2030)

Figure 52. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Type (2019-2030)

Figure 53. Global Sales Market Share of Antisense Oligonucleotides (ASOs) Drugs by Application (2019-2030)

Figure 54. Global Revenue Market Share of Antisense Oligonucleotides (ASOs) Drugs by Application (2019-2030)

Figure 55. Global Antisense Oligonucleotides (ASOs) Drugs Price (US$/Unit) by Application (2019-2030)

Figure 56. Antisense Oligonucleotides (ASOs) Drugs Value Chain

Figure 57. Antisense Oligonucleotides (ASOs) Drugs Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antisense Oligonucleotides Market Research Report 2024

Global ASO based Drug Market Research Report 2024

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024

Global Antisense ODN Market Research Report 2024

Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global CNS Specific Antisense Oligonucleotides Market Research Report 2024

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024

Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025

Global Nucleic Acid Drugs Market Research Report 2025

DNA RNA Oligonucleotides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotides Market Insights Forecast to 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions